Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023868
Filing Date
2020-05-11
Accepted
2020-05-11 08:31:22
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-10q_20200331.htm 10-Q 1420210
2 EX-31.1 scyx-ex311_8.htm EX-31.1 15622
3 EX-31.2 scyx-ex312_6.htm EX-31.2 15587
4 EX-32.1 scyx-ex321_7.htm EX-32.1 9411
  Complete submission text file 0001564590-20-023868.txt   6984347

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT scyx-20200331.xml EX-101.INS 1777869
6 XBRL TAXONOMY EXTENSION SCHEMA scyx-20200331.xsd EX-101.SCH 46361
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20200331_cal.xml EX-101.CAL 46264
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20200331_def.xml EX-101.DEF 177768
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20200331_lab.xml EX-101.LAB 420040
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20200331_pre.xml EX-101.PRE 335382
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 20862753
SIC: 2834 Pharmaceutical Preparations